Blood therapy research in Stony Brook COVID-19 patients yields promising results
The study involved more than 200 patients who were intubated at the Stony Brook hospital. Doctors adjusted the doses of blood thinners to the level of blood clotting in patients and found that it increased chances of survival.
•
Feb 24, 2021, 1:43 PM
•
Updated 1,537 days ago
Share:
More Stories
Hometown Heroes in New York City
291ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
587ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
598ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
606ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
620ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
620ds agoHometown Heroes in New York City
291ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
587ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
598ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
606ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
620ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
620ds agoNew research at Stony Brook University Hospital is showing that anti-coagulation therapies could help patients as they battle COVID-19, especially those with a predisposition to developing blood clots.
The study involved more than 200 patients who were intubated at the Stony Brook hospital. Doctors adjusted the doses of blood thinners to the level of blood clotting in patients and found that it increased chances of survival.
MORE: How will the pandemic affect doing your taxes this year? Here's what you need to know before filing
MORE: Where can I get the COVID-19 vaccine?
COVID-19 UPDATES: Live Blog
MORE: Where can I get the COVID-19 vaccine?
COVID-19 UPDATES: Live Blog
Other studies have used a fixed dose of blood thinners.
The results of the study showed that 27% of those critically ill patients who were given the treatment died as compared to 58% of critically ill patients who did not receive this protocol.
Gail Rooney, 75, of Medford, was given the treatment at Stony Brook and survived coronavirus, cancer, stroke and a blood clot.
“I don't think I'm special. I just think I'm ordinary, but people around me say I'm special,” she told News 12. “I guess the Lord doesn't want me dead. He kept me here for something.”
Dr. Apostolos Tassiopoulos, of Stony Brook University Hospital, led the study last March.
“We have looked at things that worked and things that haven't worked and we stuck with thing that clearly makes a difference,” he told News 12.
The anti-coagulation therapy is now standard at Stony Brook. Researchers say it has helped lower the COVID-19 death rate, along with other therapies.
More from News 12
2:34
Guide: Safety tips to help prevent home burglaries
2:19
Guide: Safety measures to help prevent fires and how to escape one
2:40
Mayor's budget cuts: A controversial solution amidst immigration crisis
2:07
Tips on how to avoid confrontation with sharks while swimming in the ocean
2:33
5 tips to prevent mosquito bites and getting sick from viruses
2:39
